Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 21, 2016

View Archived Issues

Veliparib does not demonstrate clinically significant QTc prolongation in phase I trial

Atrin Pharmaceuticals wins NCI contract to develop ATR inhibitors

SOBI-003 granted European orphan drug status

New Canadian-African trial to study Ebola vaccine VSV-EBOV in subjects with HIV

Redx nominates new drug development candidate from reversible BTK inhibitor program

Glucox Biotech discloses Nox4 inhibitors

CFDA accepts CStone Pharmaceuticals' IND for anti-PD-L1 monoclonal antibody

Novel DNA vaccines against Zika virus infection enter phase I study

Ionis Pharmaceuticals presents promising clinical data for IONIS-APO(a)Rx and IONIS-APO(a)-LRx

NBE Therapeutics and SOTIO to develop next-generation ADCs

FDA grants rare pediatric disease designation to Kuros Biosciences' KUR-112

Institute of Materia Medica of Beijing patents deoxytylophorinine derivatives

Merck & Co. describes novel azacarbazole derivatives

Bristol-Myers Squibb identifies new AP2-associated protein kinase 1 inhibitors

Araxes Pharma presents novel KRAS Gly12Cys mutant inhibitors

Enanta Pharmaceuticals divulges anti-hepatitis B virus agents

Twice daily DA-5204 equal to thrice daily Stillen for treating gastritis

Advaxis begins part B of KEYNOTE-046 trial

ProMetic Life Sciences reports results from phase II study of PBI-4050

EMA awards priority medicine designation to CymaBay Therapeutics' MBX-8025

NIH grant to support study of Capricor Therapeutics' CAP-2003

HedgePath Pharmaceuticals provides interim data from phase IIb study of SUBA-Itraconazole

Debiopharm enters clinical collaboration with Merck KGaA and Pfizer

Karolinska Development company Dilaforette to change name to Modus Therapeutics

Positive topline results from FORWARD-5 pivotal phase III study of ALKS-5461 in patients with MDD

FIT phase III trials and open-label extension study show consistent benefit of fostamatinib

High rate of response seen with dabrafenib in pediatric low-grade gliomas

Johnson & Johnson offers overview of third quarter 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Sun Pharma to acquire Merck spinoff Organon for $11.75B
BioWorld
Sun Pharmaceuticals Industries Ltd. will pay $11.75 billion cash to acquire Organon & Co. The transaction is expected to close in early 2027. The addition of...